Statera BioPharma (STU:7CB) EV-to-Revenue : (As of Jun. 23, 2024)

Statera BioPharma EV-to-Revenue Chart

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EV-to-Revenue	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Statera BioPharma's EV-to-Revenue

For the Biotechnology subindustry, Statera BioPharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Statera BioPharma's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's EV-to-Revenue falls into.

Statera BioPharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Statera BioPharma's EV-to-Revenue for today is calculated as:

Statera BioPharma's current Enterprise Value is €0.00 Mil.
Statera BioPharma's Revenue for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma  (STU:7CB) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Statera BioPharma's PS Ratiofor today is calculated as:

Statera BioPharma's share price for today is €0.00.
Statera BioPharma's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Statera BioPharma (STU:7CB) Business Description